Job description
Patient Access Program Lead, you will play a pivotal role in establishing the vision, strategies, and future capabilities of our Roche Assist (Patient Access & Services) program in Malaysia. Your strategic planning and operational expertise will help drive patient access strategies in the patient value chain, ensuring that patients receive the support they need throughout their healthcare journey. The Opportunity:Define the Roche Assist strategy and priorities in collaboration with Patient Access Managers. Act as a coach and mentor to team members and support teams.Participate in the Access360 Network to leverage insights for improving the patient experience.Establish a vendor partnership framework to enable strategic partnerships.Develop KPIs, metrics, dashboards, performance reports, and action plans. Maintain oversight of conversion, allocation, and delivery of goods for Roche Assist programs.Develop and maintain local SOPs for proper document and records management and ensure compliance with Roche Directives and other guidance documents.Maintain the License-to-Operate for program execution, including business compliance and GxP requirements. Continuously improve the performance of Roche Assist operations.Stay updated on industry trends and pending legislation impacting programs. Strategize and establish a BCM plan for program tools/platforms/databases.
Responsibilities & skills
Excellent leadership and mentoring abilities.Knowledge of compliance and business continuity management.Strong communication and collaboration skills.
Education
Bachelor's degree in a relevant field.Strong experience in patient access programs or related areas.
Experience
Ready to apply?
Sign in and make sure your profile and resume are up to date.
Roche
Roche was one of the first companies to bring targeted treatments to patients. With our combined strength in pharmaceuticals and diagnostics, we are better equipped than any other company to further drive personalised healthcare. Two-thirds of our Research and Development projects are being developed with companion diagnostics.We are the world's number 1 in biotech with 17 biopharmaceuticals on the market. Over half of the compounds in our product pipeline are biopharmaceuticals, enabling us to deliver better-targeted therapies.We have been at the forefront of cancer research and treatment for over 50 years, with medicines for breast, skin, colon, ovarian, lung and numerous other cancers.We offer doctors profound information to guide treatments and to answer more patients’ questions than any other company. And our tests enable hospitals and labs to deliver that information quickly and reliably.We invest around 9 billion Swiss francs in Research and Development every year because innovation is our lifeblood. This is amongst the highest Research and Development spends in the world across all industries.
View company profile